Ganciclovir delivery through an intravitreal microdialysis probe in rabbit

Acta Ophthalmologica Scandinavica

Volumn 78, Issue 3, 2000, Pages 369-371

  Waga, Janina ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cytomegalovirus retinitis; Ganciclovir; Microdialysis probe

Indexed keywords

GANCICLOVIR; TRACER; TRITIUM; TRITIUM OXIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CYTOMEGALOVIRUS INFECTION; DRUG DELIVERY SYSTEM; DRUG IMPLANTATION; DRUG TISSUE LEVEL; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RABBIT; RETINITIS; SUSTAINED DRUG RELEASE; VITREOUS BODY;

ANIMALS; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS RETINITIS; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; DRUG IMPLANTS; GANCICLOVIR; MICRODIALYSIS; RABBITS; VITREOUS BODY;

EID: 0034031452     PISSN: 13953907     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0420.2000.078003369.x     Document Type: Article

References (15)

1. Ames A & Nesbett FB (1981): In vitro retina as an experimental model of central nervous system. J Neurochem 37: 867-877.
2. Anand R, Font RL, Fish RH, Nightingale SD (1993): Pathology of cytomegalovirus retinitis treated with sustained release intravitreal ganciclovir. Ophthalmology 100: 1032-1039.
3. Berthe P, Baudoiun C, Garraffo R, Hofmann P, Tauberet A-M & Lapalus P (1994): Toxicologic and pharmacokinetic analysis of intravitreal injections of Foscarnet, either alone or in combination with Ganciclovir. Invest Ophthalmol Vis Sci 35: 1038-1045.
4. Boyer DS & Posalski J (1999): Potential complication with removal of ganciclovir implants. Am J Ophthalmol 127: 349-350.
5. Daikos GL, Pulido J, Kathpalia SB & Jackson GG (1988): Intravenous and intraocular ganciclovir for CMV retinitis in patients with AIDS or chemotherapeutic immunosuppresion. Br J Ophthalmol 72: 521-524.
6. Davis JL, Tbandeh H, Feuer WJ, Kumbhat S, Roth DB & Chaudrhy NA (1999): Effect of potent antiretroviral therapy on recurrent cytomegalovirus retinitis treated with ganciclovir implant. Am J Ophthalmol 137: 283-287.
7. Hughes PM, Krishnamoorthy R & Mitra AK (1996): Vitreous disposition of two acycloguanosine antivirals in the albino and pigmented rabbit models: a novel ocular microdialysis technique. J Ocul Pharmacol Ther 12: 209-224.
8. Martin DF, Parks DJ, Mellow SD, Ferris FL, Walton C, Remaley NA, Chew EY, Ashton P, Davis MD & Nussenblatt RB (1994): Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant. Arch Ophthalmol 112: 1531-1539.
9. Martin DF, Ferris FL, Parks DJ, Walton C, Mellow SD, Gibbs D, Remaley NA, Ashton P, Davis MD, Chan C-C & Nussenblatt RB (1997): Ganciclovir implant exchange. Arch Ophthalmol 115: 1389-1394.
10. Peyman GA, Khoobehi B, Tawakol M, Schulman JA, Mortada HA, Alkan H & Fiscella R (1987): Intravitreal injection of liposome-encapsulated ganciclovir in a rabbit model. Retina 7: 227-229.
11. Roth DB, Feuer WJ, Blenke AJ & Davis JL (1999): Treatment of recurrent cytomegalovirus retinitis with the ganciclovir implant. Am J Ophthalmol 127: 276-282.
12. Ungerstedt U (1984): Measurement of neurotransmitter release by intracranial analysis. Marsden CA (ed): in: Measurement of neurotransmitter release in vivo Pp. 81-105. John Wiley & Sons Ltd, New York - Brisbane - Toronto.
13. Waga J, Ohta A & Ehinger B (1991): Intraocular microdialysis with permanently implanted probes in rabbit. Acta Ophthalmol Scand 69: 618-624.
14. Waga J & Ehinger B (1995): Passage of drugs through different intraocular microdialysis membranes. Graefes's Arch Clin Exp Ophthalmol 233: 31-37.
15. Waga J & Ehinger B (1997): Intravitreal concentrations of some drugs administered with microdialysis. Acta Ophthalmol Scand 75: 36-40.